Reply to correspondence on “Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial”

Saved in:
Bibliographic Details
Main Authors: Hiroaki Kanzaki, Yujin Hoshida
Format: Article
Language:English
Published: Korean Association for the Study of the Liver 2025-01-01
Series:Clinical and Molecular Hepatology
Subjects:
Online Access:http://e-cmh.org/upload/pdf/cmh-2024-0886.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!